免费体验“高时效”国际投行研报“T+0至T+1”“原研报”可至底部下载高盛——泰格医药（3347.HK）——减值拖累2025年四季度盈利，订单势头印证2026年复苏翻译精华1. 2025年业绩：营收超预期，盈利受减值影响不及预期：泰格医药2026年1月29日盘后披露2025年业绩预告，营收为66.6-76.8亿元（中点71.7亿元，同比+9%），高于高盛预期的67.97亿元及Visible ...
Source Link免费体验“高时效”国际投行研报“T+0至T+1”“原研报”可至底部下载高盛——泰格医药（3347.HK）——减值拖累2025年四季度盈利，订单势头印证2026年复苏翻译精华1. 2025年业绩：营收超预期，盈利受减值影响不及预期：泰格医药2026年1月29日盘后披露2025年业绩预告，营收为66.6-76.8亿元（中点71.7亿元，同比+9%），高于高盛预期的67.97亿元及Visible ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.